What’s New
We share news about new product features, our thoughts on recent developments at MedaSystems or in the industry at large. Scroll down for a chronological view, or jump to posts using the categories to the left.
How Expanded Access Programs Are Evolving in 2026
For patients facing serious or life-threatening conditions, waiting for full regulatory approval of a promising therapy is often not an option. Expanded Access Programs (EAPs), sometimes referred to as compassionate use programs, have long provided a regulatory pathway for patients to receive investigational treatments outside of clinical trials.
Why Expanded Access Programs Often Originate in Medical Affairs
Expanded Access Programs (EAPs) - also known as compassionate use—play a critical role in bridging the gap between clinical development and patient need.
Navigating the AI Frontier: How to Leverage Real-World Data to Advance Expanded Access Program Outcomes
Expanded Access Programs (EAPs) are a critical pathway for patients with serious or life-threatening conditions to access investigational therapies outside of clinical trials.